Consolidative and salvage thoracic radiotherapy (TRT) in extensive-stage small-cell lung cancer (ES-SCLC) with first-line chemoimmunotherapy: a retrospective study from a single cancer center

被引：0
|
作者：
Lan, Aihua [1 ,2 ,3 ,4 ]
Dong, Huiling [1 ]
Zheng, Zhiqin [5 ]
Chu, Xiao [1 ,2 ,3 ,4 ]
Zhu, Zhengfei [1 ,2 ,3 ,4 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[3] Shanghai Clin Res Ctr Radiat Oncol, Shanghai, Peoples R China
[4] Shanghai Key Lab Radiat Oncol, Shanghai, Peoples R China
[5] Fudan Univ, Shanghai Canc Ctr, Minhang Branch Hosp, Dept Radiat Oncol, Shanghai, Peoples R China
来源：
LANCET REGIONAL HEALTH-WESTERN PACIFIC | 2025年 / 55卷
关键词：
Extensive-stage small-cell lung cancer; Immunotherapy; Survival; Thoracic radiotherapy;
D O I：
10.1016/j.lanwpc.2024.101373
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Second-line treatment outcomes following first-line chemotherapy plus immunotherapy in patients with extensive-stage small cell lung cancer (ES-SCLC): A multicenter study.
    Pons-Tostivint, Elvire
    Ezzedine, Remy
    Goronflot, Thomas
    Crequit, Perrine
    Chatellier, Thierry
    Raimbourg, Judith
    Bennouna, Jaafar
    Leprieur, Etienne Giroux
    Porte, Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] Chemoimmunotherapy as the First-Line Treatment for Patients With Extensive-Stage Small-Cell Lung Cancer and an ECOG Performance Status 2 or 3
    Agarwal, Muskan
    Liu, Alex
    Langlais, Blake T.
    Leventakos, Konstantinos
    Yu, Nathan Y.
    Almquist, Daniel
    Manochakian, Rami
    Ernani, Vinicius
    CLINICAL LUNG CANCER, 2023, 24 (07) : 591 - 597
  • [33] Extensive-Stage Small-Cell Lung Cancer: First-Line and Second-Line Treatment Options
    Zugazagoitia, Jon
    Paz-Ares, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06) : 671 - +
  • [34] French real world study on patient characteristics and treatment strategies in first-line of extensive-stage small cell lung cancer (ES SCLC)
    Debieuvre, D.
    Dayen, C.
    Dixmier, A.
    Gally, S.
    Pau, D.
    Greenwood, W.
    Falchero, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S1038 - S1038
  • [35] First-line apatinib plus chemotherapy in extensive-stage small-cell lung cancer.
    Shi, Jian
    Liu, Jiayin
    Duan, Xiaoyang
    Huang, Guanglei
    Wang, Lixing
    Zhao, Yan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [36] Economic Evaluation of First-Line Atezolizumab for Extensive-Stage Small-Cell Lung Cancer in the US
    Wang, Yingcheng
    Rui, Mingjun
    Yang, Lan
    Wang, Xintian
    Shang, Ye
    Ma, Aixia
    Li, Hongchao
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [37] Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not?
    Jing Luo
    Liming Xu
    Lujun Zhao
    Yuanjie Cao
    Qingsong Pang
    Jun Wang
    Zhiyong Yuan
    Ping Wang
    Radiation Oncology, 12
  • [38] Phase II study of anlotinib plus durvalumab and chemotherapy as first-line treatment in extensive-stage small cell lung cancer (ES-SCLC): Efficacy and safety analysis.
    Chen, Lijuan
    Zhao, Yanqiu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [39] Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not?
    Luo, Jing
    Xu, Liming
    Zhao, Lujun
    Cao, Yuanjie
    Pang, Qingsong
    Wang, Jun
    Yuan, Zhiyong
    Wang, Ping
    RADIATION ONCOLOGY, 2017, 12
  • [40] Efficacy of 3D conformal thoracic radiotherapy for extensive-stage small-cell lung cancer: A retrospective study
    Luan, Zupeng
    Wang, Zhiwu
    Huang, Wei
    Zhang, Jian
    Dong, Wei
    Zhang, Wei
    Li, Baosheng
    Zhou, Tao
    Li, Hongsheng
    Zhang, Zicheng
    Wang, Zhongtang
    Sun, Hongfu
    Yi, Yan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (02) : 671 - 678
12345